TYSON TIMOTHY

CIK 00012074055 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001207405

Recent Transactions

50 trades

Award
Syros Pharmaceuticals, Inc.
Common Stock
2024-06-05+4,000→ 33,189 total
Award
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2024-06-05+6,000→ 6,000 total
Award
Syros Pharmaceuticals, Inc.
Common Stock
2023-06-01+4,000→ 29,189 total
Award
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2023-06-01+6,000→ 6,000 total
Purchase
Syros Pharmaceuticals, Inc.
Common Stock
2022-09-30$6.37/sh+14,000→ 24,932 total
Purchase
Syros Pharmaceuticals, Inc.
Common Stock
2022-09-29$5.72/sh+2,932→ 10,932 total
Award
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2022-09-16+12,000→ 12,000 total
Award
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2022-09-16+2,232→ 2,232 total
Award
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2022-09-16+1,094→ 1,094 total
Award
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2022-09-16+2,191→ 2,191 total
Award
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2022-09-16+3,856→ 3,856 total
Award
Syros Pharmaceuticals, Inc.
Common Stock
2022-09-16+8,000→ 8,000 total
Award
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2022-09-16+12,000→ 12,000 total
Award
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2022-09-16+3,856→ 3,856 total
Award
Syros Pharmaceuticals, Inc.
Common Stock
2022-09-16+8,000→ 8,000 total
Award
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2022-09-16+3,286→ 3,286 total
Award
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2022-09-16+2,191→ 2,191 total
Award
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2022-09-16+2,848→ 2,848 total
Award
Syros Pharmaceuticals, Inc.
Common Stock
2022-09-16+257→ 8,257 total
Disposition to Issuer
TYME TECHNOLOGIES, INC.
Director Stock Option - Option to buy
2022-09-16−50,058→ 0 total
Disposition to Issuer
TYME TECHNOLOGIES, INC.
Director Stock Option - Option to buy
2022-09-16−65,000→ 0 total
Disposition to Issuer
TYME TECHNOLOGIES, INC.
Director Stock Option - Option to buy
2022-09-16−75,000→ 0 total
Disposition to Issuer
TYME TECHNOLOGIES, INC.
Director Stock Option - Option to buy
2022-09-16−88,000→ 0 total
Disposition to Issuer
TYME TECHNOLOGIES, INC.
Director Stock Option - Option to buy
2022-09-16−25,000→ 0 total
Disposition to Issuer
TYME TECHNOLOGIES, INC.
Director Stock Option - Option to buy
2022-09-16−50,000→ 0 total
Disposition to Issuer
TYME TECHNOLOGIES, INC.
Director Stock Option - Option to buy
2022-09-16−50,000→ 0 total
Disposition to Issuer
TYME TECHNOLOGIES, INC.
Director Stock Option - Option to buy
2022-09-16−88,000→ 0 total
Disposition to Issuer
TYME TECHNOLOGIES, INC.
Common Stock
2022-09-16−5,865→ 0 total
Award
TYME TECHNOLOGIES, INC.
Director Stock Option - Option to buy
2022-08-24+88,000→ 88,000 total
Award
TYME TECHNOLOGIES, INC.
Director Stock Option - Option to buy
2021-08-24+88,000→ 88,000 total
Award
TYME TECHNOLOGIES, INC.
Director Stock Option - right to buy
2020-08-20+65,000→ 65,000 total
Award
TYME TECHNOLOGIES, INC.
Director Stock Option - right to buy
2019-08-22+50,000→ 50,000 total
Award
Icagen, Inc.
Stock Option
2018-11-14+25,000→ 25,000 total
Award
Icagen, Inc.
Stock Option
2018-11-14+100,000→ 100,000 total
Award
TYME TECHNOLOGIES, INC.
Director Stock Option - right to buy
2018-08-26+50,000→ 50,000 total
Award
Icagen, Inc.
Warrant
2018-08-13+45,000→ 45,000 total
Award
Icagen, Inc.
Series C Convertible Preferred Stock
2018-07-13+114,284→ 685,704 total
Award
Icagen, Inc.
Warrant
2018-07-13+114,284→ 685,704 total
Award
TYME TECHNOLOGIES, INC.
Director Stock Option - right to buy
2018-05-24+75,000→ 75,000 total
Award
Icagen, Inc.
Warrant
2018-04-04+571,428→ 571,428 total
Award
Icagen, Inc.
Series C Convertible Preferred Stock
2018-04-04+571,428→ 571,428 total
Award
Icagen, Inc.
Warrant
2017-12-29$0.02/sh+5,357→ 5,357 total
Purchase
Icagen, Inc.
Common Stock
2017-12-29$0.37/sh+21,428→ 164,284 total
Award
TYME TECHNOLOGIES, INC.
Director Stock Option - right to buy
2017-11-22+50,958→ 50,958 total
Exercise/Conversion
BIODELIVERY SCIENCES INTERNATIONAL INC
Common Stock
2017-08-14+3,658→ 4,658 total
Exercise/Conversion
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Units
2017-08-14−3,658→ 3,657 total
Award
BIODELIVERY SCIENCES INTERNATIONAL INC
Stock Options
2017-07-14$2.64/sh+3,658→ 3,658 total
Award
BIODELIVERY SCIENCES INTERNATIONAL INC
Restricted Stock Unit
2017-07-14+7,315→ 7,315 total
Award
Icagen, Inc.
Warrant
2017-04-12+75,000→ 75,000 total
Award
Icagen, Inc.
Stock Option
2017-03-15+10,000→ 10,000 total

Companies

Recent Filings

Address

C/O ONE KENDALL SQUARE, SUITE B2002

CAMBRIDGE, MA, 02139

View on SEC.gov